Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
| ▸ | F7 | P08709 | 1/20 | 0.54 |
| ▸ | F3 | P13726 | 1/20 | 0.54 |
| ▸ | SARM1 | Q6SZW1 | 1/20 | 0.54 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.54 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.54 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.54 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.54 |
| ▸ | SIRT4 | Q9Y6E7 | 1/20 | 0.54 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.54 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.51 |
| ▸ | PIM1 | P11309 | 1/20 | 0.51 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18640729 | 0.87 | LMNA (0.56) | LMNAHIF1AROCK2ROCK1HDAC1 | |
| SCHEMBL6542858 | 0.83 | KDM4E (0.60) | LMNAHIF1AROCK2ROCK1HTT | |
| SCHEMBL30142618 | 0.82 | HDAC1 (0.67) | LMNAHIF1AROCK2ROCK1HDAC1 | |
| SCHEMBL21905480 | 0.82 | HDAC1 (0.67) | LMNAHIF1AROCK2ROCK1HDAC1 | |
| SCHEMBL1233669 | 0.82 | ALDH1A1 (0.59) | SIRT2SMN1; SMN2KDM4EALDH1A1HPGD | |
| SCHEMBL7287487 | 0.81 | SIRT2 (0.76) | SIRT2LMNAHIF1AF7F3 | |
| SCHEMBL28824956 | 0.80 | RAB9A (0.66) | HTTL3MBTL1SMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL6643666 | 0.77 | LMNA (0.67) | LMNAHIF1AROCK2ROCK1HDAC1 | |
| SCHEMBL30932625 | 0.77 | TLR7 (0.56) | LMNAHIF1AALDH1A1HSD17B10TDP1 | |
| SCHEMBL2714517 | 0.77 | MAPT (0.65) | SIRT2LMNAHTTSMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108368493-A | Enzymatic system and method for synthesizing nicotinamide mononucleotide and niacin mononucleotide | 新南创新私人有限公司 | 2018-08-03 | — | — | CN | disclosed |
| EP-2906050-B1 | DIETARY COMPOSITIONS COMPRISING CAPSULES OBTAINED BY COACERVATION WITHOUT THE USE OF TOXIC CROSS-LINKING AGENTS | SOC D EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2018-04-25 | — | — | EP | disclosed |
| CN-104883900-A | Dietary composition comprising capsules obtained by coacervation without toxic cross-linking agents | SEPPIC SA | 2015-09-02 | — | — | CN | disclosed |
| US-20150230499-A1 | DIETARY COMPOSITIONS COMPRISING CAPSULES OBTAINED BY COACERVATION WITHOUT THE USE OF TOXIC CROSS-LINKING AGENTS | SOCIETE D'EXPLOITATION DE PRODUITS PUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2015-08-20 | — | — | US | disclosed |
| EP-2906050-A1 | DIETARY COMPOSITIONS COMPRISING CAPSULES OBTAINED BY COACERVATION WITHOUT THE USE OF TOXIC CROSS-LINKING AGENTS | Societe D Exploitation De Produits Pour Les Industries Chimiques Seppic (FR) | 2015-08-19 | — | — | EP | disclosed |
| US-20130344167-A1 | Galenic Composition Suitable for Administration to a Non-Human Animal, Uses Thereof, and Associated Methods | VETALIS SARL (FR) | 2013-12-26 | — | — | US | disclosed |
| EP-2646004-A2 | GALENIC COMPOSITION SUITABLE FOR ADMINISTRATION TO A NON-HUMAN ANIMAL, USES THEREOF, AND ASSOCIATED METHODS | Vetalis Sarl (FR) | 2013-10-09 | — | — | EP | disclosed |
| WO-2012073170-A2 | GALENIC COMPOSITION SUITABLE FOR ADMINISTRATION TO A NON-HUMAN ANIMAL, USES THEREOF, AND ASSOCIATED METHODS | VETALIS SARL (FR) | 2012-06-07 | — | — | WO | disclosed |
| WO-2012017363-A1 | EFFERVESCENT SOLID GALENIC FORMS FOR ANIMALS | VETALIS SARL (FR) | 2012-02-09 | — | — | WO | disclosed |
| CN-1668324-A | Methods, compositions and growth and differentiation factors for insulin producing cells | NOVOCELL INC (US) | 2005-09-14 | — | — | CN | disclosed |
| US-20040259244-A1 | Methods, compositions, and growth and differentiation factors for insulin-producing cells | BECTON, DICKINSON AND COMPANY, CO-ASSIGNOR | 2004-12-23 | — | — | US | disclosed |
| US-20040132183-A1 | Methods and compositions for expanding and differentiating insulin-producing cells | NOVOCELL, INC. | 2004-07-08 | — | — | US | disclosed |
| US-6013250-A | FOR FINISHING EFFECT AND SUPERIOR PROTECTION AGAINST ENVIRONMENTAL, CHEMICAL, AND GROOMING-ASSOCIATED DAMAGE | L'OREAL S. A. (FR) | 2000-01-11 | — | — | US | disclosed |
| US-5681554-A | CONTAINING DIVALENT CATION, HYDROLYZED PROTEIN AND A VITAMIN | COSMAIR, INC. (US) | 1997-10-28 | — | — | US | disclosed |